US Stock MarketDetailed Quotes

NEPH Nephros

Watchlist
  • 1.520
  • -0.078-4.86%
Close Jan 8 16:00 ET
  • 1.520
  • 0.0000.00%
Post 20:01 ET
16.03MMarket Cap-16.89P/E (TTM)

Nephros Key Stats

Nephros Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
3.47M
3.52M
+44.00K
Beat Est.
-7.16%
-5.99%
+1.27%
EPS
-0.02
0.02
+0.04
Beat Est.
0.00%
+200.00%
+200.50%
Buy

Dec 31, 2024

Nephros Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 3.603M --
-- 2024/Q4 -- / 3.570M --
Nov 7, 2024 2024/Q3 3.518M / 3.474M --
Aug 8, 2024 2024/Q2 3.252M / 3.861M --
May 9, 2024 2024/Q1 3.522M / 3.734M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.603M--
--2024/Q4-- / 3.570M--
Nov 7, 20242024/Q33.518M / 3.474M--
Aug 8, 20242024/Q23.252M / 3.861M--
May 9, 20242024/Q13.522M / 3.734M--

Unlock Free Earnings Estimates

Nephros Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data